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As the leading cause of cancer death in women in the United States, lung cancer is a considerable 
public health burden. While smoking cessation is an effective strategy for cancer prevention, 
additional approaches are necessary to help prevent the over 300,000 worldwide lung cancer deaths 
a year that are not attributable to tobacco use. In women, roughly half of lung cancer cases are not 
attributable to smoking. Emerging evidence has suggested that vitamin D concentrations may be 
associated with lung cancer risk and mortality, though perhaps only among certain subgroups. A 
recent report in The American Journal of Clinical Nutrition by Dr. Ting-Yuan David Cheng and 
colleagues, under the direction of Dr. Marian L. Neuhouser in the Public Health Sciences Division, 
found that increased vitamin D intake was associated with a lower lung cancer risk in never-smoking 
postmenopausal women. 
To investigate this potential relationship between vitamin D intake and lung cancer risk, the 
researchers analyzed data from the nearly 130,000 postmenopausal women participating in the 
Women’s Health Initiative (WHI), including 1,771 lung cancer cases. This large sample size was 
instrumental in making this study possible, notes lead author Cheng, "particularly the number of 
never smokers and detailed data on dietary intake and supplemental vitamin use collected by the 
WHI." The effect of total vitamin D intake on lung cancer risk was evaluated both categorically and 
linearly using Cox proportional hazard models. Never smokers were defined as those having 
smoked fewer than 100 cigarettes in their lifetime.  
Initial evaluations, looking at the effect of vitamin D intake across all women, showed no effect. 
Given the subgroup-specific effects seen in previous studies, the authors also performed the 
analysis stratified by smoking status. While no effect was seen in current or former smokers, an 
inverse association was observed in never smokers.  In this group, total vitamin D intake was 
statistically significantly associated with lower risk of lung cancer (P-trend = 0.01). Compared to a 
vitamin D intake of less than 100 IU/day, intakes of 400-599 and 600-799 IU/d were associated with 
a 45% reduction in risk (Hazard Ratio (HR) = 0.55), while a 63% reduction in risk was seen for ≥800 
IU/day (HR = 0.37). 
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In further analyses by histological subtype of lung cancer, this reduction in risk in never smokers was 
similarly observed for adenocarcinoma (HR 0.34) and non-small cell lung cancer (HR 0.37) for ≥400 
versus <100 IU/day. Interestingly, adenocarcinomas tend to occur more often in never smokers than 
in smokers. The authors hypothesize that, at least for adenocarcinoma, the anti-carcinogenic 
functions of vitamin D may more effectively prevent or reverse mutations that are not tobacco-
related, compared with tobacco-induced mutations.  Additional research will be needed to further 
evaluate the biological mechanisms of this relationship, and to see whether vitamin D intake similarly 
reduces lung cancer risk in other groups, such as never-smoking men or premenopausal women.  
Overall, "this study provides new evidence that vitamin D obtained from diet and vitamin 
supplements is associated with a lower risk of lung cancer in never-smoking women," states Cheng, 
which "is important because it gives us clues that insufficient vitamin D intake may be a new risk 
factor of lung cancer and we may be able to use vitamin D to prevent lung cancer in this population." 
This finding suggests that postmenopausal women who have already reduced their risk of lung 
cancer by never smoking may further reduce their lung cancer risk by ensuring they have sufficient 
total intake of vitamin D. 
Other PHS investigators contributing to this project were Drs. Andrea Z. LaCroix, Shirley A.A. 
Beresford, Gary E. Goodman, Mark D. Thornquist, and Yingye Zheng. 
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Image provided by David Cheng. 
In the human body, vitamin D is converted in the liver to 25-
hydroxyvitamin D, which is the standard biomarker of vitamin 
D status for research and clinical use. This form is further 
converted in the kidney to 1,25-di-hydroxyvitamin D, which is 
the active form of vitamin D. This form activates vitamin D 
receptors, which regulate numerous functions including cell 
cycles in the lungs. 
 
